Page 271 - ILAE_Lectures_2015

16. NOACHTAR, S., ANDERMANN, E., MEYVISCH, P., ANDERMANN, F., GOUGH, W.B., SCHIEMANN-
DELGADO, J. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.

Neurology 2008; 70(8): 60716.
17. GLAUSER, T.A., CNAAN, A., SHINNAR, S. et al. Ethosuximide, valproic acid, and lamotrigine in

childhood absence epilepsy. N Engl J Med 2010; 362(9): 7909.
18. BRODIE, M.J., YUEN, A.W. Lamotrigine substitution study: evidence for synergism with sodium valproate?

105 Study Group. Epilepsy Res 1997; 26(3): 42332.
19. MACDONALD, B.K., JOHNSON, A.L., GOODRIDGE, D.M., COCKERELL, O.C., SANDER, J.W.,

SHORVON, S.D. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000;

48(6): 83341.
20. TUAN, N.A., TOMSON, T., ALLEBECK, P., CHUC, N.T., CUONG-LE Q. The treatment gap of epilepsy

in a rural district of Vietnam: a study from the EPIBAVI project. Epilepsia 2009; 50(10): 23203.